SAN FRANCISCO, November 23, 2015 /PRNewswire/ --
Global vascular graft market is expected to reach USD 3,626 million by 2022, according to a new study by Grand View Research, Inc. Key factors attributing to its rapid growth include increasing prevalence of cardiovascular diseases coupled with the development of technological advanced novel tissue engineered biomaterial based vascular graft.
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Furthermore, rising healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce vascular graft market growth over the next seven years.
Vascular graft market is segmented on the basis of type of raw material that includes polyester, polytetrafluoroethylene, polyurethane and biological materials. Biological materials are further classified as human saphenous & umbilical veins and tissue engineered materials. Key factors attributing to rapidly growing demand for biomaterial based graft are higher acceptability of these graft in human body and reduced risk of post surgery complication associated with tissue engineered and human saphenous vein based graft.
Browse full research report with TOC on "Vascular Graft Market Analysis by Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral vascular, Coronary Artery By-pass Graft), by Application (Cardiovascular Diseases, Cardiac Aneurysm, Kidney Failure, Vascular Occlusion), by Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials) and Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/vascular-graft-market
Rising demand for biomaterial vascular graft and technological advancements pertaining to novel product development such as Nellix and Fortevo will boost usage rates over the forecast period.
Key applications analyzed in the report include cardiovascular diseases, aneurysm, kidney failure, vascular occlusion and diabetes. Key factors driving the market growth include increasing geriatric population base which is highly prone to cardiac disorders and unhealthy lifestyle habits such as alcohol consumption & smoking.
Vascular graft industry is further segmented on the basis of products that include hemodialysis access graft, endovascular stent graft, peripheral vascular graft and coronary artery bypass graft. High volume of EVAR procedures is a high impact rendering driver attributing for the large share of endovascular stent graft.
Further key findings from the report suggest:
Grand View Research has segmented the vascular graft market on the basis of product, application, raw material and region:
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - esorics2010.org, legalworkshop.org
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com
Share this article